H

Harmony Biosciences Holdings
D

HRMY

34.530
USD
-0.38
(-1.09%)
مغلق
حجم التداول
17,468
الربح لكل سهم
4
العائد الربحي
-
P/E
16
حجم السوق
1,969,290,685
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Harmony Biosciences Holdings

القطاع: Healthcare
الصناعة: Biotechnology
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX(pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.